Mitsumasa Kondo

772 total citations
7 papers, 524 citations indexed

About

Mitsumasa Kondo is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Mitsumasa Kondo has authored 7 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hepatology. Recurrent topics in Mitsumasa Kondo's work include Epigenetics and DNA Methylation (3 papers), Pluripotent Stem Cells Research (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). Mitsumasa Kondo is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Pluripotent Stem Cells Research (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). Mitsumasa Kondo collaborates with scholars based in Japan and United States. Mitsumasa Kondo's co-authors include Masao Honda, Takehiro Hayashi, Yasumasa Hara, Kouki Nio, Taro Yamashita, Sha Zeng, Tatsuya Yamashita, Ken‐ichi Arai, Noriko Sato and Naoki Oishi and has published in prestigious journals such as Journal of the American Chemical Society, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Mitsumasa Kondo

7 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitsumasa Kondo Japan	6	346	211	158	126	33	7	524
Jiamin Cheng China	9	277 0.8×	155 0.7×	173 1.1×	98 0.8×	34 1.0×	26	498
Kevin S. Quackenbush United States	12	228 0.7×	219 1.0×	112 0.7×	27 0.2×	31 0.9×	17	423
Agnes Csiszar Austria	8	205 0.6×	227 1.1×	92 0.6×	58 0.5×	23 0.7×	12	428
Sanchaika Gaur United States	5	202 0.6×	91 0.4×	173 1.1×	38 0.3×	17 0.5×	7	343
Florence Defresne Belgium	10	161 0.5×	53 0.3×	166 1.1×	36 0.3×	44 1.3×	15	340
Weimin Hu United States	8	305 0.9×	188 0.9×	79 0.5×	20 0.2×	17 0.5×	10	431
Man Xia China	12	253 0.7×	73 0.3×	170 1.1×	35 0.3×	35 1.1×	22	399
Hanna Nyström Sweden	10	108 0.3×	154 0.7×	103 0.7×	30 0.2×	31 0.9×	18	275
Guiqi Zhu China	8	147 0.4×	128 0.6×	137 0.9×	70 0.6×	25 0.8×	13	376
Longwei Jiang China	9	487 1.4×	163 0.8×	345 2.2×	18 0.1×	33 1.0×	14	653

Countries citing papers authored by Mitsumasa Kondo

Since Specialization

Citations

This map shows the geographic impact of Mitsumasa Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsumasa Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsumasa Kondo more than expected).

Fields of papers citing papers by Mitsumasa Kondo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsumasa Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsumasa Kondo. The network helps show where Mitsumasa Kondo may publish in the future.

Co-authorship network of co-authors of Mitsumasa Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsumasa Kondo. A scholar is included among the top collaborators of Mitsumasa Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsumasa Kondo. Mitsumasa Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hara, Yasumasa, Taro Yamashita, Naoki Oishi, et al.. (2015). TSU-68 ameliorates hepatocellular carcinoma growth by inhibiting microenvironmental platelet-derived growth factor signaling.. PubMed. 35(3). 1423–31. 7 indexed citations

2.

Nio, Kouki, Taro Yamashita, Hikari Okada, et al.. (2015). Defeating EpCAM+ liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma. Journal of Hepatology. 63(5). 1164–1172. 76 indexed citations

3.

Zeng, Sha, Taro Yamashita, Mitsumasa Kondo, et al.. (2013). The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. Journal of Hepatology. 60(1). 127–134. 116 indexed citations

4.

Yamashita, Taro, Masao Honda, Yasunari Nakamoto, et al.. (2012). Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology. 57(4). 1484–1497. 226 indexed citations

5.

Sato, Noriko, Mitsumasa Kondo, & Ken‐ichi Arai. (2006). The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct-3/4 silencing. Biochemical and Biophysical Research Communications. 344(3). 845–851. 68 indexed citations

6.

Aso, Mariko, et al.. (2000). A Novel Method of Preparing Amine-Modifying C-4' Oxidized Nucleotide.. Chemical and Pharmaceutical Bulletin. 48(9). 1384–1386. 1 indexed citations

7.

Aso, Mariko, Mitsumasa Kondo, Hiroshi Suemune, & Sidney M. Hecht. (1999). Chemistry of the Bleomycin-Induced Alkali-Labile DNA Lesion. Journal of the American Chemical Society. 121(39). 9023–9033. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact